Jeffrey Matthews to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Jeffrey Matthews has written about Drug Resistance, Neoplasm.
Connection Strength
0.164
-
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. Cell Rep Med. 2023 12 19; 4(12):101312.
Score: 0.164